Indeed, in tumor infiltrating lymphocytes, an increasing gradient of GR expression and signaling from naïve to dysfunctional CD8+ T cells was found, suggesting that endogenous GCs also promote T cell dysfunction and tumor growth (66). The gene discussed is NR3C1; the disease is neoplasm.